Market Overview:
The global male infertility market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of male infertility, rising awareness about male infertility treatments, and technological advancements in the field of assisted reproductive technologies (ART). The global male infertility market by type is segmented into ART, artificial insemination (AI), fertility surgery, fertility drugs, and others. The ART segment accounted for the largest share of the global male infertility market in 2017 and is expected to grow at a CAGR of 7.8% from 2018 to 2030. This growth can be attributed to the increasing use of ART procedures such as intracytoplasmic sperm injection (ICSI) and pre-implantation genetic diagnosis (PGD) for treating male infertility. The global Male Infertility Market by application is segmented into fertility clinics, hospitals, research banks, and others.
Product Definition:
Male infertility is a condition where a man is unable to impregnate a woman. This can be caused by problems with the sperm, such as low sperm count or poor motility, or by anatomical problems that block the passage of sperm. Male infertility is important because it accounts for half of all infertility cases.
ART:
ART (Assisted Reproductive Technology) is also known as In-vitro fertilization. It is a process where the husband’s sperm and the wife’s egg are brought together under controlled conditions to enable a pregnancy. The most common technique used in ART is IVF (In-vitro fertilization).
The global market for ART was valued at USD 9 billion in 2015.
Artificial Insemination:
Artificial Insemination is the process by which a man's sperm is collected from his testicles and mixed with an egg (the female reproductive organ). The resulting embryo is then transferred to the uterus for development.
The procedure can be done in two ways: With Micro-Technological help & Without Micro-Technological help.
Application Insights:
Based on application, the market is segmented into fertility clinics, hospitals and research banks. Fertility clinics held the largest share of over 60% in 2017. This can be attributed to rising number of IVF procedures being performed at a clinic level as well as increasing adoption of assisted reproductive technology (ART) for male infertility at this level.
The use of artificial insemination for treating male infertility was one of the first applications that led to significant commercialization in fertility industry. The development of artificial semenatozoa by researchers at University College London (UCL), which can be used for intrauterine insemination without involving males or females has significantly boosted market growth over last few years.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high adoption of modern technologies and a large number of infertility patients are some factors attributing to its largest share. In addition, the availability of highly advanced ART drugs is expected to drive growth during the forecast period.
Asia Pacific is estimated to be one of the fastest growing regions over the forecast period owing to a rise in awareness about male infertility and related issues coupled with government initiatives for creating an enabling environment for treatment options through improved healthcare facilities at affordable costs. Moreover, increasing medical tourism due to affordability will also boost demand for fertility treatments in this region over the next eight years.
Growth Factors:
- Increasing awareness about male infertility and its treatment options among people.
- Growing number of infertile couples seeking treatment for infertility.
- Rising incidence of male infertility due to lifestyle and environmental factors.
- Advances in assisted reproductive technologies (ART) that help in the treatment of male infertility.
- Increased funding for research on male fertility and development of new treatments for male infertility
Scope Of The Report
Report Attributes
Report Details
Report Title
Male Infertility Market Research Report
By Type
ART, Artificial Insemination, Fertility Surgery, Fertility Drugs, Others
By Application
Fertility Clinics, Hospitals, Research Banks
By Companies
Male Infertility, CCRM, Ferring Pharmaceuticals, Merck & Co, Monash IVF, The Cooper, Thermo Fisher
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Male Infertility Market Report Segments:
The global Male Infertility market is segmented on the basis of:
Types
ART, Artificial Insemination, Fertility Surgery, Fertility Drugs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fertility Clinics, Hospitals, Research Banks
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Male Infertility
- CCRM
- Ferring Pharmaceuticals
- Merck & Co
- Monash IVF
- The Cooper
- Thermo Fisher
Highlights of The Male Infertility Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ART
- Artificial Insemination
- Fertility Surgery
- Fertility Drugs
- Others
- By Application:
- Fertility Clinics
- Hospitals
- Research Banks
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Male Infertility Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Male infertility is the inability of a man to produce sperm.
Some of the major companies in the male infertility market are Male Infertility, CCRM, Ferring Pharmaceuticals, Merck & Co, Monash IVF, The Cooper, Thermo Fisher.
The male infertility market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Male Infertility Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Male Infertility Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Male Infertility Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Male Infertility Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Male Infertility Market Size & Forecast, 2018-2028
4.5.1 Male Infertility Market Size and Y-o-Y Growth
4.5.2 Male Infertility Market Absolute $ Opportunity
Chapter 5 Global Male Infertility Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Male Infertility Market Size Forecast by Type
5.2.1 ART
5.2.2 Artificial Insemination
5.2.3 Fertility Surgery
5.2.4 Fertility Drugs
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Male Infertility Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Male Infertility Market Size Forecast by Applications
6.2.1 Fertility Clinics
6.2.2 Hospitals
6.2.3 Research Banks
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Male Infertility Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Male Infertility Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Male Infertility Analysis and Forecast
9.1 Introduction
9.2 North America Male Infertility Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Male Infertility Market Size Forecast by Type
9.6.1 ART
9.6.2 Artificial Insemination
9.6.3 Fertility Surgery
9.6.4 Fertility Drugs
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Male Infertility Market Size Forecast by Applications
9.10.1 Fertility Clinics
9.10.2 Hospitals
9.10.3 Research Banks
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Male Infertility Analysis and Forecast
10.1 Introduction
10.2 Europe Male Infertility Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Male Infertility Market Size Forecast by Type
10.6.1 ART
10.6.2 Artificial Insemination
10.6.3 Fertility Surgery
10.6.4 Fertility Drugs
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Male Infertility Market Size Forecast by Applications
10.10.1 Fertility Clinics
10.10.2 Hospitals
10.10.3 Research Banks
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Male Infertility Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Male Infertility Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Male Infertility Market Size Forecast by Type
11.6.1 ART
11.6.2 Artificial Insemination
11.6.3 Fertility Surgery
11.6.4 Fertility Drugs
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Male Infertility Market Size Forecast by Applications
11.10.1 Fertility Clinics
11.10.2 Hospitals
11.10.3 Research Banks
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Male Infertility Analysis and Forecast
12.1 Introduction
12.2 Latin America Male Infertility Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Male Infertility Market Size Forecast by Type
12.6.1 ART
12.6.2 Artificial Insemination
12.6.3 Fertility Surgery
12.6.4 Fertility Drugs
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Male Infertility Market Size Forecast by Applications
12.10.1 Fertility Clinics
12.10.2 Hospitals
12.10.3 Research Banks
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Male Infertility Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Male Infertility Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Male Infertility Market Size Forecast by Type
13.6.1 ART
13.6.2 Artificial Insemination
13.6.3 Fertility Surgery
13.6.4 Fertility Drugs
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Male Infertility Market Size Forecast by Applications
13.10.1 Fertility Clinics
13.10.2 Hospitals
13.10.3 Research Banks
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Male Infertility Market: Competitive Dashboard
14.2 Global Male Infertility Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Male Infertility
14.3.2 CCRM
14.3.3 Ferring Pharmaceuticals
14.3.4 Merck & Co
14.3.5 Monash IVF
14.3.6 The Cooper
14.3.7 Thermo Fisher
